Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
- PMID: 20096762
- DOI: 10.1016/j.vaccine.2010.01.002
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation
Abstract
Decisions on how to mitigate an evolving pandemic are technically challenging. We present a real-time assessment of the effectiveness and cost-effectiveness of alternative influenza A/H1N1v vaccination strategies. A transmission dynamic model was fitted to the estimated number of cases in real-time, and used to generate plausible autumn scenarios under different vaccination options. The proportion of these cases by age and risk group leading to primary care consultations, National Pandemic Flu Service consultations, emergency attendances, hospitalisations, intensive care and death was then estimated using existing data from the pandemic. The real-time model suggests that the epidemic will peak in early November, with the peak height being similar in magnitude to the summer wave. Vaccination of the high-risk groups is estimated to prevent about 45 deaths (80% credibility interval 26-67), and save around 2900 QALYs (80% credibility interval 1600-4500). Such a programme is very likely to be cost-effective if the cost of vaccine purchase itself is treated as a sunk cost. Extending vaccination to low-risk individuals is expected to result in more modest gains in deaths and QALYs averted. Extending vaccination to school-age children would be the most cost-effective extension. The early availability of vaccines is crucial in determining the impact of such extensions. There have been a considerable number of cases of H1N1v in England, and so the benefits of vaccination to mitigate the ongoing autumn wave are limited. However, certain groups appear to be at significantly higher risk of complications and deaths, and so it appears both effective and cost-effective to vaccinate them. The United Kingdom was the first country to have a major epidemic in Europe. In countries where the epidemic is not so far advanced vaccination of children may be cost-effective. Similar, detailed, real-time modelling and economic studies could help to clarify the situation.
Similar articles
-
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.Vaccine. 2006 Nov 17;24(47-48):6812-22. doi: 10.1016/j.vaccine.2006.07.042. Epub 2006 Aug 4. Vaccine. 2006. PMID: 17034909
-
Vaccines against influenza A (H1N1) pandemic.Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008. Arch Med Res. 2009. PMID: 20304259
-
Health and economic impact of the seasonal influenza vaccination programme in England.Vaccine. 2012 May 14;30(23):3459-62. doi: 10.1016/j.vaccine.2012.03.019. Epub 2012 Mar 22. Vaccine. 2012. PMID: 22446636
-
[Prophylactic influenza vaccination: what is the situation in Germany?].Dtsch Med Wochenschr. 2006 Mar 3;131(9):453-7. doi: 10.1055/s-2006-932543. Dtsch Med Wochenschr. 2006. PMID: 16493571 Review. German.
-
The 2009 A (H1N1) influenza virus pandemic: A review.Vaccine. 2010 Jul 12;28(31):4895-902. doi: 10.1016/j.vaccine.2010.05.031. Epub 2010 May 27. Vaccine. 2010. PMID: 20553769 Review.
Cited by
-
Forecasting and control of emerging infectious forest disease through participatory modelling.Philos Trans R Soc Lond B Biol Sci. 2019 Jul 8;374(1776):20180283. doi: 10.1098/rstb.2018.0283. Philos Trans R Soc Lond B Biol Sci. 2019. PMID: 31104598 Free PMC article. Review.
-
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29. PLoS One. 2011. PMID: 21829456 Free PMC article.
-
Comparing the immunogenicity of AS03-adjuvanted 2009 pandemic H1N1 vaccine with clinical protection in priority risk groups in England.PLoS One. 2013;8(2):e56844. doi: 10.1371/journal.pone.0056844. Epub 2013 Feb 22. PLoS One. 2013. PMID: 23451097 Free PMC article.
-
Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.PLoS One. 2015 Mar 26;10(3):e0120138. doi: 10.1371/journal.pone.0120138. eCollection 2015. PLoS One. 2015. PMID: 25811654 Free PMC article.
-
Transmission dynamics of the 2009 influenza A (H1N1) pandemic in India: the impact of holiday-related school closure.Epidemics. 2013 Dec;5(4):157-63. doi: 10.1016/j.epidem.2013.08.001. Epub 2013 Aug 28. Epidemics. 2013. PMID: 24267871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical